Gene-Edited Trees: A Lifeline for Florida’s Citrus Industry?

Florida’s citrus industry is a behemoth, with an annual economic impact of $10 billion and a workforce of over 50,000 people. However, the sector faces an existential threat from diseases such as greener leafworm and Huanglongbing (HLB), also known as citrus greening.

A collapse of the industry would have far-reaching consequences for cities like Orlando and Miami, which rely heavily on tourism and agriculture, as well as countless families who rely on citrus farming for their income. Moreover, Florida’s agricultural sector is vulnerable to market fluctuations in other crops, making it crucial to find a solution to the industry’s problems.

Gene-editing technology may hold the key to saving the industry by developing engineered trees that possess built-in resistance to diseases such as HLB and greener leafworm. By identifying genes associated with disease resistance, researchers can introduce them into citrus trees, creating new crops better equipped to fend off infection.

This technology is already being explored in various agricultural sectors. In the United States, gene-edited corn and soybeans have been developed to be resistant to certain pests and diseases. The results have been impressive: yields have increased, pesticide use has decreased, and farmers’ profits have risen accordingly.

Scientists are working on introducing genes that inhibit the spread of the HLB-causing bacterium Candidatus Liberibacter asiaticus (C. L. a.). These genes can be introduced into the tree’s DNA using CRISPR-Cas9, a gene editing tool that has revolutionized genetic engineering. One potential solution is to introduce a gene called ‘xylem sap flow’, which would help flush out the disease-causing bacteria from the tree’s vascular system.

Developing gene-edited citrus trees for commercial production is not without its challenges, however. Regulatory hurdles need to be cleared before these new crops can be widely adopted by farmers. In many countries, including the United States, gene-edited crops are classified as genetically modified organisms (GMOs) and therefore subject to stringent regulations.

There is currently no clear consensus on how to classify gene-edited crops – with some arguing that they should be treated the same way as conventionally bred varieties, while others believe they require more rigorous testing. This regulatory limbo has slowed down the development of these new crops.

Gene editing is an imperfect science, and not all trees may take up the introduced genes in equal measure. Introducing disease-resistant traits does not guarantee complete immunity – other factors such as climate change and pests remain a threat. Despite these hurdles, researchers believe that collaboration between scientists, farmers, and regulators is key to bringing gene-edited citrus trees to market.

This requires industry stakeholders to work together, sharing knowledge and expertise to ensure that new crops are both effective and safe for consumers. As one researcher noted, ‘the development of gene-edited citrus trees will not be a solo effort – it will require collaboration across sectors’. With such a high-stakes challenge ahead, this kind of commitment is crucial.